TY - JOUR
T1 - Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
AU - Wei, Gong Hong
AU - Badis, Gwenael
AU - Berger, Michael F.
AU - Kivioja, Teemu
AU - Palin, Kimmo
AU - Enge, Martin
AU - Bonke, Martin
AU - Jolma, Arttu
AU - Varjosalo, Markku
AU - Gehrke, Andrew R.
AU - Yan, Jian
AU - Talukder, Shaheynoor
AU - Turunen, Mikko
AU - Taipale, Mikko
AU - Stunnenberg, Hendrik G.
AU - Ukkonen, Esko
AU - Hughes, Timothy R.
AU - Bulyk, Martha L.
AU - Taipale, Jussi
PY - 2010/7/7
Y1 - 2010/7/7
N2 - Members of the large ETS family of transcription factors (TFs) have highly similar DNA-binding domains (DBDs)yet they have diverse functions and activities in physiology and oncogenesis. Some differences in DNA-binding preferences within this family have been described, but they have not been analysed systematically, and their contributions to targeting remain largely uncharacterized. We report here the DNA-binding profiles for all human and mouse ETS factors, which we generated using two different methods: a high-throughput microwell-based TF DNA-binding specificity assay, and protein-binding microarrays (PBMs). Both approaches reveal that the ETS-binding profiles cluster into four distinct classes, and that all ETS factors linked to cancer, ERG, ETV1, ETV4 and FLI1, fall into just one of these classes. We identify amino-acid residues that are critical for the differences in specificity between all the classes, and confirm the specificities in vivo using chromatin immunoprecipitation followed by sequencing (ChIP-seq) for a member of each class. The results indicate that even relatively small differences in in vitro binding specificity of a TF contribute to site selectivity in vivo.
AB - Members of the large ETS family of transcription factors (TFs) have highly similar DNA-binding domains (DBDs)yet they have diverse functions and activities in physiology and oncogenesis. Some differences in DNA-binding preferences within this family have been described, but they have not been analysed systematically, and their contributions to targeting remain largely uncharacterized. We report here the DNA-binding profiles for all human and mouse ETS factors, which we generated using two different methods: a high-throughput microwell-based TF DNA-binding specificity assay, and protein-binding microarrays (PBMs). Both approaches reveal that the ETS-binding profiles cluster into four distinct classes, and that all ETS factors linked to cancer, ERG, ETV1, ETV4 and FLI1, fall into just one of these classes. We identify amino-acid residues that are critical for the differences in specificity between all the classes, and confirm the specificities in vivo using chromatin immunoprecipitation followed by sequencing (ChIP-seq) for a member of each class. The results indicate that even relatively small differences in in vitro binding specificity of a TF contribute to site selectivity in vivo.
KW - ancer
KW - ChIP-seq
KW - DNA-binding specificity
KW - ETS family of transcription factors
KW - transcription factor-DNA binding assay
UR - http://www.scopus.com/inward/record.url?scp=77954954652&partnerID=8YFLogxK
U2 - 10.1038/emboj.2010.106
DO - 10.1038/emboj.2010.106
M3 - Article
C2 - 20517297
AN - SCOPUS:77954954652
SN - 0261-4189
VL - 29
SP - 2147
EP - 2160
JO - EMBO Journal
JF - EMBO Journal
IS - 13
ER -